Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial (TOSCA IT)
Effects on Incidence of Cardiovascular Events of the Addition of Pioglitazone as Compared With a Sulphonylurea in Type 2 Diabetic Patients Inadequately Controlled With Metformin.
Sponsor: Associazione Medici Diabetologi (AMD)
Listed as NCT00700856, this PHASE4 trial focuses on Cardiovascular Disease and Type 2 Diabetes Mellitus and remains ongoing. Sponsored by Associazione Medici Diabetologi (AMD), it has been updated 7 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jan 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Sep 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Associazione Medici Diabetologi (AMD)
- Associazione Nazionale Medici Cardiologi Ospedalieri
- Italian Society of Diabetology
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ancona, Italy , Arezzo, Italy , Atri, Italy , Bari, Italy , Bergamo, Italy , Bologna, Italy , Campobasso, Italy , Catania, Italy , Catanzaro, Italy , Cesena, Italy and 42 more locations